Mast Therapeutics Inc (NYSEMKT:MSTX) and privately held pharmaceutical firm Savara Inc. have announced the intent to merge to advance a novel pipeline of …
Canaccord analyst John Newman is out today with a favorable research report on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) after the firm’s competition, Phase 3 …
After market-close yesterday, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) released positive second Phase 3 results for plecanatide, the firm’s pipeline daily pill designed to treat …
Yesterday, Radius Health Inc (NASDAQ:RDUS) shares rose a solid 6% on back of RAD-1901 Phase 1 study clinical data that proved to be better …
Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares were thundering down 19% yesterday after news came to light that the firm has withdrawn its Investigational New …
In a research report released Friday, Canaccord analyst John Newman reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with a $13 price …
In a research report published Monday, Canaccord analyst John Newman reiterated a Buy rating on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), with a …
Canaccord analyst John Newman speculates on Palatin Technologies, Inc. (NYSEMKT:PTN) ahead of clinical data and partnership updates with a bullish forecast, reiterating a …
Palatin Technologies, Inc. (NYSEMKT:PTN) shares jumped 18% today after the company’s key pipeline drug bremelanotide, designed to treat female sexual dysfunction (FSD), hit …
In a research report published Thursday, Canaccord analyst John Newman reiterated a Buy rating on shares of Celgene Corporation (NASDAQ:CELG) with a price target …